| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453580 | Lung Cancer | 2018 | 33 Pages |
Abstract
NCDB data demonstrate increasing use of surgery-based treatments and SBRT for Stage II NSCLC over time. Radiation-based therapies were associated with decreased survival compared to surgery. CFR was associated with decreased survival compared to chemoradiation and SBRT.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sherry X. Yan, Muhammad M. Qureshi, Kei Suzuki, Michael Dyer, Minh Tam Truong, Virginia Litle, Kimberley S. Mak,